BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16014560)

  • 21. CD40 ligand, Bcl-2 and apoptosis in B-chronic lymphocytic leukemia.
    Hussein OA; Omran AA; Elnaggar AM; Fathy A
    Egypt J Immunol; 2009; 16(2):27-36. PubMed ID: 22059351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity.
    Schattner EJ; Mascarenhas J; Reyfman I; Koshy M; Woo C; Friedman SM; Crow MK
    Blood; 1998 Apr; 91(8):2689-97. PubMed ID: 9531577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy.
    Krackhardt AM; Harig S; Witzens M; Broderick R; Barrett P; Gribben JG
    Blood; 2002 Jul; 100(1):167-73. PubMed ID: 12070023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation.
    Elmetwali T; Salman A; Wei W; Hussain SA; Young LS; Palmer DH
    Sci Rep; 2020 Jan; 10(1):342. PubMed ID: 31941968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia.
    Biagi E; Rousseau R; Yvon E; Schwartz M; Dotti G; Foster A; Havlik-Cooper D; Grilley B; Gee A; Baker K; Carrum G; Rice L; Andreeff M; Popat U; Brenner M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6916-23. PubMed ID: 16203783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis.
    van Attekum MHA; van Bruggen JAC; Slinger E; Lebre MC; Reinen E; Kersting S; Eldering E; Kater AP
    Haematologica; 2017 Dec; 102(12):2069-2076. PubMed ID: 28971904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40 activation: potential for specific immunotherapy in B-CLL.
    von Bergwelt-Baildon M; Maecker B; Schultze J; Gribben JG
    Ann Oncol; 2004 Jun; 15(6):853-7. PubMed ID: 15151939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
    Hammond C; Shi Y; Mena J; Tomic J; Cervi D; He L; Millar AE; Debenedette M; Schuh AC; Baryza JL; Wender PA; Radvanyi L; Spaner DE
    J Immunother; 2005; 28(1):28-39. PubMed ID: 15614042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
    van Attekum MHA; Terpstra S; Slinger E; von Lindern M; Moerland PD; Jongejan A; Kater AP; Eldering E
    Oncogene; 2017 Jun; 36(26):3651-3660. PubMed ID: 28192408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.
    Girbl T; Hinterseer E; Grössinger EM; Asslaber D; Oberascher K; Weiss L; Hauser-Kronberger C; Neureiter D; Kerschbaum H; Naor D; Alon R; Greil R; Hartmann TN
    Cancer Res; 2013 Jan; 73(2):561-70. PubMed ID: 23117883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential of gene transfer into primary B-CLL cells using recombinant virus vectors.
    Wendtner CM; Kofler DM; Mayr C; Bund D; Hallek M
    Leuk Lymphoma; 2004 May; 45(5):897-904. PubMed ID: 15291346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of T cell/B cell interaction by B-CLL cells.
    Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
    Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells.
    Dotti G; Savoldo B; Yotnda P; Rill D; Brenner MK
    Blood; 2002 Jul; 100(1):200-7. PubMed ID: 12070028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.
    Ghia P; Strola G; Granziero L; Geuna M; Guida G; Sallusto F; Ruffing N; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
    Eur J Immunol; 2002 May; 32(5):1403-13. PubMed ID: 11981828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.
    Cols M; Barra CM; He B; Puga I; Xu W; Chiu A; Tam W; Knowles DM; Dillon SR; Leonard JP; Furman RR; Chen K; Cerutti A
    J Immunol; 2012 Jun; 188(12):6071-83. PubMed ID: 22593611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
    Takahashi S; Yotnda P; Rousseau RF; Mei Z; Smith S; Rill D; Younes A; Brenner MK
    Cancer Gene Ther; 2001 May; 8(5):378-87. PubMed ID: 11477458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.